Advances in Imaging Modalities and Contrast Agents for the Early Diagnosis of Colorectal Cancer.

J Biomed Nanotechnol

Huaxi MR Research Center (HMRRC), Department of Radiology, Functional and Molecular Imaging Key Laboratory of Sichuan Province, West China Hospital, Sichuan University, Chengdu, 610041, China.

Published: April 2021

Colorectal cancer is one of the most common gastrointestinal cancers worldwide. The mortality rate of colorectal cancer has declined by more than 20% due to the rapid development of early diagnostic techniques and effective treatment. At present, there are many diagnostic modalities available for the evaluation of colorectal cancer, such as the carcinoembryonic antigen test, the fecal occult blood test, endoscopy, X-ray barium meal, computed tomography, magnetic resonance imaging, and radionuclide examination. Sensitive and specific imaging modalities have played an increasingly important role in the diagnosis of colorectal cancer following the rapid development of novel contrast agents. This review discusses the applications and challenges of different imaging techniques and contrast agents applied to detect colorectal cancer, for the purpose of the early diagnosis and treatment of patients with colorectal cancer.

Download full-text PDF

Source
http://dx.doi.org/10.1166/jbn.2021.3064DOI Listing

Publication Analysis

Top Keywords

colorectal cancer
28
contrast agents
12
imaging modalities
8
early diagnosis
8
diagnosis colorectal
8
rapid development
8
colorectal
7
cancer
7
advances imaging
4
modalities contrast
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!